Stay current with MiRXES

Media Coverage

Stay informed and keep abreast with our media news.

20 Sep 2021

MiRXES, a Singapore biotechnology startup, has appointed Dr David Capes as its senior vice president and new global head of innovation on Sept 20.

8 Jul 2021

MiRXES has raised US$77 million in a Series C round, pushing  to commercialise its early cancer detection test kits globally. This latest round values the biotech at over US$500 million and could pave the way for a public listing.

Media and Investor Contact

For media enquiries, please email:

Copyright © 2021 MiRXES Pte Ltd. All rights reserved. | Privacy Policy
Scroll to Top